Johanna Nikkola

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. ncbi request reprint Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma
    Johanna Nikkola
    Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland
    Melanoma Res 14:29-37. 2004
  2. ncbi request reprint High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma
    Johanna Nikkola
    Department of Oncology and Radiotherapy, Turku University Hospital, Finland
    Clin Cancer Res 11:5158-66. 2005
  3. ncbi request reprint High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma
    Johanna Nikkola
    Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland
    Int J Cancer 97:432-8. 2002

Detail Information

Publications3

  1. ncbi request reprint Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma
    Johanna Nikkola
    Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland
    Melanoma Res 14:29-37. 2004
    ..0033). Our results suggest that beta1 and alphav integrin chains are independently expressed in metastatic melanoma and may have an effect on the metastatic potential of melanoma cells...
  2. ncbi request reprint High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma
    Johanna Nikkola
    Department of Oncology and Radiotherapy, Turku University Hospital, Finland
    Clin Cancer Res 11:5158-66. 2005
    ..In the present work, we have studied the prognostic significance of serum levels of gelatinase B (MMP-9), collagenase-1 (MMP-1), and collagenase-3 (MMP-13) in patients with advanced melanoma...
  3. ncbi request reprint High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma
    Johanna Nikkola
    Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland
    Int J Cancer 97:432-8. 2002
    ..0284). Our findings suggest that MMP-1 and -3 may have a special role in melanoma metastasis formation and thus they could be used to measure the biological activity of the disease...